FDA Warns Against Amanita Muscaria Mushroom Edibles

FDA Warns Against Amanita Muscaria Mushroom Edibles

The U.S. Food and Drug Administration (FDA) has issued a warning to manufacturers and consumers about the use of Amanita Muscaria mushrooms, especially in food products. This announcement targets the increasing presence of Amanita Muscaria, or fly agaric mushrooms, in items like gummies, chocolates, and other edible forms, which have raised concerns over potential risks.

Looking for treatment? Find ketamine clinics closest to you as well as other psychedelic therapies in your area.

Amanita Muscaria: A Powerful Mushroom

Amanita Muscaria, commonly known as the fly agaric mushroom, is known for its psychoactive effects. Unlike psilocybin mushrooms, which contain psilocybin, Amanita Muscaria contains the compounds muscimol and ibotenic acid. These substances can induce hallucinations, confusion, and altered states of consciousness, but their effects are unpredictable and can vary depending on dosage. Despite its long history of use in some traditional cultures, Amanita Muscaria poses unique risks when consumed, particularly in unregulated food products.

New: Interested in Being Part of a Psychedelics-Focused Clinical Trial? Sign Up Here

Here’s a Breakdown of the Differences Between Amanita Muscaria and Psilocybe Cubensis

AspectAmanita MuscariaPsilocybe Cubensis
Common NameFly AgaricGolden Teacher, B+ (and other varieties)
Active CompoundsMuscimol, Ibotenic AcidPsilocybin, Psilocin
Psychoactive EffectsHallucinations, altered perception, sedation, confusion, nausea, vomiting, dizzinessVisual and auditory hallucinations, altered thinking, euphoria, spiritual experiences
Onset Time30 minutes to 2 hours20 to 40 minutes
Duration of Effects4 to 6 hours (depending on dosage)4 to 6 hours
ToxicityCan be toxic in high doses, may cause vomiting, seizures, or deliriumGenerally considered non-toxic in moderate doses
Cultural UseTraditional use in Siberian and Nordic shamanic practices, often in ritualistic contextsUsed for spiritual and therapeutic purposes in modern times
LegalityIn the United States it is currently legal at the federal level, but not specifically regulatedLegal only in select regions for therapeutic or religious purposes
PreparationMust be dried and prepared carefully to avoid toxicity; boiling may reduce toxinsTypically consumed dried or fresh, often eaten or brewed in tea
AppearanceRed cap with white spots (often depicted in folklore)Light brown cap with a bell-shaped, sometimes conical appearance
Legal Status in the U.S.Not specifically regulated at the federal level, but subject to state lawsIllegal at the federal level, but legal in select states for medicinal or religious use
Risk of OverdoseHigh risk of overdose due to unpredictable effects and potential toxicityLow risk of overdose when used responsibly
Therapeutic ResearchMinimal research, often considered unsafe for self-explorationGrowing body of research supporting therapeutic use in mental health treatment

FDA’s Letter to Manufacturers: A Warning

The FDA issued a letter to manufacturers, alerting them to the risks of incorporating Amanita Muscaria into food items. The letter specifically highlights the lack of sufficient safety data on these mushrooms when consumed in food forms. The FDA’s concern centers around the potential for “adverse health consequences. Which includes vomiting, seizures, and delirium” from consuming improperly prepared or dosed Amanita Muscaria products.

Psychedelic AI is Here! Try out the beta version of HealingChat, HealingMaps AI chatbot that takes all our vetted content, clinics and retreats to answer all your questions in a safe environment. Try the beta version now!

In the letter, the FDA emphasized that food products containing Amanita Muscaria or its constituents do not meet the agency’s standards for safety. The warning directly addresses manufacturers, advising them to halt the production of such products unless they can demonstrate that the products are safe for human consumption. The FDA’s action follows reports of products on the market that contain Amanita Muscaria in various edible forms, which may be enticing to consumers unaware of the serious health risks.

The Impact on Consumers

For consumers, the FDA’s warning highlights the need for caution when considering products containing Amanita Muscaria. While the mushroom may be marketed as a psychedelic or alternative wellness product, its unpredictable effects and potential for toxicity make it dangerous when consumed in an uncontrolled manner. The FDA encourages consumers to avoid these products until they are subject to proper regulation and safety testing.

The FDA’s letter to manufacturers makes it clear that any food product containing Amanita Muscaria must meet rigorous safety standards before being sold. As the FDA continues to monitor these products, consumers are urged to stay informed and ensure that any psychedelic-related products they consume are properly labeled and regulated.

A Changing Landscape for Psychedelics

This FDA alert reflects the broader conversation about the regulation of psychedelics in the U.S. As interest in psychedelics grows, particularly for therapeutic purposes, the need for clear safety guidelines has never been more important.

The FDA’s warning is part of a broader effort to ensure public safety as more psychedelic products enter the market. While the therapeutic potential of substances like psilocybin is being explored, it’s clear that products containing Amanita Muscaria must be handled with caution. The agency’s ongoing work will likely influence how these substances are approached in the years to come.

Learn More About Magic Mushrooms Strains

Interested in learning more about the different varieties of magic mushrooms strains? Click through our menu below for a deeper dive into each strain.

Healing Maps Editorial Staff

Healing Maps Editorial Staff

View all posts by Healing Maps Editorial Staff

The Healing Maps Editorial Team has decades of experience across all facets of the psychedelic industry. From assessing studies and clinic research, to working with clinician's and clinics, we help provide data-backed information to psychedelic-curious individuals across the globe.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Explore Psychedelic Therapy Regions